NICOLE MARSHALL: Open Payments
NPI 1295497709 · GLOUCESTER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$517 in 21 payments from 10 companies in 2025. Trend: 2023 $357 · 2024 $160 · 2025 $517
Food & beverage: $517
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $160 |
| Novo Nordisk Inc | 4 | $85 |
| Amgen Inc. | 4 | $60 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Eisai Inc. | 1 | $30 |
| Phadia US Inc. | 1 | $25 |
| Exact Sciences Corporation | 1 | $21 |
| Antares Pharma, Inc. | 1 | $15 |
Products named: MOUNJARO, REXULTI, OTEZLA, AIRSUPRA, Leqembi, ImmunoCAP, Cologuard Collection Kit, AREXVY.
Industry payments across VA — which companies pay providers there.
